Long Corridor Asset Management Ltd Trims Incyte Corporation Stake

Institutional investor sells 170,000 shares of biotech company's stock

Mar. 8, 2026 at 12:21pm

Got story updates? Submit your updates here. ›

Long Corridor Asset Management Ltd, an institutional investor, has trimmed its position in Incyte Corporation (NASDAQ:INCY) by selling 170,000 shares. The firm now owns 50,000 shares of the biopharmaceutical company's stock, making it the 12th largest position in its investment portfolio.

Why it matters

This transaction highlights the shifting investment strategies of institutional investors in the biotech sector. Incyte is a prominent player in the industry, and changes to major shareholders' positions can signal broader trends or concerns about the company's outlook.

The details

According to a disclosure with the Securities and Exchange Commission, Long Corridor Asset Management Ltd sold 170,000 shares of Incyte Corporation during the third quarter. This reduced the firm's holdings in the company by 77.3%, leaving it with 50,000 shares worth approximately $4.24 million. Incyte makes up around 1.7% of Long Corridor Asset Management Ltd's total investment portfolio.

  • The share sale occurred during the third quarter of the reporting period.

The players

Long Corridor Asset Management Ltd

An institutional investor that has trimmed its position in Incyte Corporation.

Incyte Corporation

A biopharmaceutical company focused on the discovery, development and commercialization of novel therapies in oncology and inflammation.

Got photos? Submit your photos here. ›

The takeaway

This transaction suggests that some institutional investors may be reevaluating their positions in the biotech sector, potentially in response to broader market conditions or specific concerns about Incyte's outlook. However, the company remains a significant holding for Long Corridor Asset Management Ltd, indicating the firm still sees value in the stock.